Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-16 Purchase | 2022-11-18 4:31 pm | LUMOS PHARMA Inc | LUMO | McCracken Joseph S Director | 4,000 | $5.03 | $20,120 | 15,721 (Direct) | View |
| 2022-09-21 Purchase | 2022-09-23 5:05 pm | LUMOS PHARMA Inc | LUMO | Hawkins Richard J CEO | 2,422 | $8.8366 | $21,402 | 752,712 (Indirect Direct) | View |
| 2022-09-19 Purchase | 2022-09-21 6:45 pm | LUMOS PHARMA Inc | LUMO | Hawkins Richard J CEO | 2,047 | $8.7236 | $17,857 | 750,290 (Indirect Direct) | View |
| 2022-08-25 Purchase | 2022-08-26 5:00 pm | LUMOS PHARMA Inc | LUMO | Raffin Thomas A. Director | 1,150 | $8.46 | $9,729 | 9,406 (Direct) | View |
| 2022-08-25 Purchase | 2022-08-26 4:59 pm | LUMOS PHARMA Inc | LUMO | McCracken Joseph S Director | 3,170 | $8.6 | $27,262 | 11,721 (Direct) | View |
| 2022-08-01 Sale | 2022-08-03 11:25 am | LUMOS PHARMA Inc | LUMO | McKew John C. Chief Scientific Officer | 3,407 | $8.11 | $27,631 | 24,602 (Direct) | View |
| 2022-06-06 Sale | 2022-06-07 4:23 pm | LUMOS PHARMA Inc | LUMO | McKew John C. Chief Scientific Officer | 169 | $7.62 | $1,288 | 29,102 (Direct) | View |
| 2022-04-01 Sale | 2022-04-05 5:29 pm | LUMOS PHARMA Inc | LUMO | McKew John C. Chief Scientific Officer | 2,214 | $8.32 | $18,420 | 29,271 (Direct) | View |
| 2021-09-08 Sale | 2021-09-10 4:58 pm | LUMOS PHARMA Inc | LUMO | McKew John C. Chief Scientific Officer | 2,214 | $11.3 | $25,018 | 31,012 (Direct) | View |
| 2021-09-08 Purchase | 2021-09-10 4:57 pm | LUMOS PHARMA Inc | LUMO | LALANDE KEVIN M. Director | 10,000 | $11.21 | $112,116 | 731,522 (Indirect Direct) | View |
| 2021-09-02 Purchase | 2021-09-07 5:56 pm | LUMOS PHARMA Inc | LUMO | LALANDE KEVIN M. Director | 24,400 | $11.22 | $273,783 | 721,522 (Indirect Direct) | View |
| 2021-08-30 Purchase | 2021-09-01 6:46 pm | LUMOS PHARMA Inc | LUMO | LALANDE KEVIN M. Director | 19,214 | $10.66 | $204,811 | 697,122 (Indirect Direct) | View |
| 2021-08-25 Purchase | 2021-08-27 7:16 pm | LUMOS PHARMA Inc | LUMO | LALANDE KEVIN M. Director | 26,081 | $10.04 | $261,790 | 678,908 (Indirect Direct) | View |
| 2021-08-20 Purchase | 2021-08-24 6:19 pm | LUMOS PHARMA Inc | LUMO | LALANDE KEVIN M. Director | 84,254 | $9.2062 | $775,660 | 652,827 (Indirect Direct) | View |
| 2021-08-17 Purchase | 2021-08-19 8:14 pm | LUMOS PHARMA Inc | LUMO | LALANDE KEVIN M. Director | 64,870 | $8.5775 | $556,426 | 568,573 (Indirect Direct) | View |
| 2021-08-12 Purchase | 2021-08-16 6:09 pm | LUMOS PHARMA Inc | LUMO | LALANDE KEVIN M. Director | 93,000 | $7.7892 | $724,393 | 503,703 (Indirect Direct) | View |
| 2021-08-11 Purchase | 2021-08-13 4:32 pm | LUMOS PHARMA Inc | LUMO | Schuchart Aaron Chief Business Officer | 2,000 | $7.4095 | $14,819 | 3,037 (Direct) | View |
| 2021-08-11 Purchase | 2021-08-13 4:31 pm | LUMOS PHARMA Inc | LUMO | McCracken Joseph S Director | 7,475 | $7.546 | $56,406 | 8,551 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-09-01 Tax Withholding | 2022-09-06 4:55 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Karpf David B Chief Medical Officer | 570 | $8.53 | 7,330 (Direct) | View |
| 2022-08-01 Tax Withholding | 2022-08-03 11:25 am | N/A N/A | LUMOS PHARMA Inc | LUMO | McKew John C. Chief Scientific Officer | 1,593 | $8.17 | 24,602 (Direct) | View |
| 2022-08-01 Tax Withholding | 2022-08-03 11:25 am | N/A N/A | LUMOS PHARMA Inc | LUMO | Lawley Lori D CFO | 229 | $8.17 | 10,119 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 5:14 pm | N/A 2032-05-04 | LUMOS PHARMA Inc | LUMO | Zoth Lota S. Director | 3,431 | $0 | 3,431 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 5:11 pm | N/A 2032-05-04 | LUMOS PHARMA Inc | LUMO | van Es-Johansson An Director | 3,431 | $0 | 3,431 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 5:10 pm | N/A 2032-05-04 | LUMOS PHARMA Inc | LUMO | Raffin Thomas A. Director | 3,431 | $0 | 3,431 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 5:09 pm | N/A 2032-05-04 | LUMOS PHARMA Inc | LUMO | McCracken Joseph S Director | 3,431 | $0 | 3,431 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 5:09 pm | N/A 2032-05-04 | LUMOS PHARMA Inc | LUMO | LALANDE KEVIN M. Director | 3,431 | $0 | 3,431 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 5:09 pm | N/A 2032-05-04 | LUMOS PHARMA Inc | LUMO | JOHNSON CHAD ALLEN Director | 3,431 | $0 | 3,431 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-05 5:29 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | POWERS BRADLEY J General Counsel | 342 | $9.23 | 5,589 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-05 5:29 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | McKew John C. Chief Scientific Officer | 1,036 | $9.23 | 29,271 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-05 5:28 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Lawley Lori D CFO | 274 | $9.23 | 9,848 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-05 5:28 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Hawkins Richard J CEO | 1,466 | $9.23 | 748,243 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:37 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Schuchart Aaron Chief Business Officer | 1,000 | $10.02 | 15,985 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:37 pm | N/A 2032-01-31 | LUMOS PHARMA Inc | LUMO | Schuchart Aaron Chief Business Officer | 12,000 | $0 | 15,985 (Direct) | View |
| 2022-02-01 Tax Withholding | 2022-02-03 4:37 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Schuchart Aaron Chief Business Officer | 52 | $10.02 | 15,985 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:36 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | POWERS BRADLEY J General Counsel | 900 | $10.02 | 16,931 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:36 pm | N/A 2032-01-31 | LUMOS PHARMA Inc | LUMO | POWERS BRADLEY J General Counsel | 11,000 | $0 | 16,931 (Direct) | View |
| 2022-02-01 Tax Withholding | 2022-02-03 4:36 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | POWERS BRADLEY J General Counsel | 78 | $10.02 | 16,931 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:36 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | McKew John C. Chief Scientific Officer | 1,500 | $10.02 | 46,521 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:36 pm | N/A 2032-01-31 | LUMOS PHARMA Inc | LUMO | McKew John C. Chief Scientific Officer | 14,000 | $0 | 46,521 (Direct) | View |
| 2022-02-01 Tax Withholding | 2022-02-03 4:36 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | McKew John C. Chief Scientific Officer | 100 | $10.02 | 46,521 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:36 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Lawley Lori D CFO | 1,000 | $10.02 | 22,122 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:36 pm | N/A 2032-01-31 | LUMOS PHARMA Inc | LUMO | Lawley Lori D CFO | 12,000 | $0 | 22,122 (Direct) | View |
| 2022-02-01 Tax Withholding | 2022-02-03 4:36 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Lawley Lori D CFO | 65 | $10.02 | 22,122 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:35 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Karpf David B Chief Medical Officer | 400 | $10.02 | 12,900 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:35 pm | N/A 2032-01-31 | LUMOS PHARMA Inc | LUMO | Karpf David B Chief Medical Officer | 5,000 | $0 | 12,900 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:34 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Hawkins Richard J CEO | 4,500 | $10.02 | 785,109 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:34 pm | N/A 2032-01-31 | LUMOS PHARMA Inc | LUMO | Hawkins Richard J CEO | 35,400 | $0 | 785,109 (Direct) | View |
| 2022-02-01 Tax Withholding | 2022-02-03 4:34 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Hawkins Richard J CEO | 173 | $10.02 | 785,109 (Direct) | View |
| 2021-09-01 Ownership | 2021-09-02 6:39 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Karpf David B Chief Medical Officer | 0 | $0 | 50,000 (Direct) | View |
| 2021-08-01 Option Award | 2021-08-03 6:09 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | McKew John C. Chief Scientific Officer | 20,000 | $0 | 33,226 (Direct) | View |
| 2021-08-01 Option Award | 2021-08-03 6:09 pm | N/A 2031-07-31 | LUMOS PHARMA Inc | LUMO | Lawley Lori D CFO | 25,000 | $0 | 30,437 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 4:52 pm | N/A 2031-05-31 | LUMOS PHARMA Inc | LUMO | Schuchart Aaron Chief Business Officer | 7,805 | $0 | 7,805 (Direct) | View |
| 2021-05-19 Ownership | 2021-05-28 7:03 pm | N/A N/A | LUMOS PHARMA Inc | LUMO | Schuchart Aaron Chief Business Officer | 0 | $0 | 54,428 (Direct) | View |